• Users Online: 73793
  • Home
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquine

Ulviye Yigit, Betul Tugcu, Nur Tarakcioglu Hatice, Selda Celik

Year : 2013| Volume: 61| Issue : 4 | Page no: 168-171

   This article has been cited by
 
1 Unveiling Ocular Manifestations in Systemic Lupus Erythematosus
Mutali Musa, Ekele Chukwuyem, Oluwasola Michael Ojo, Efioshiomoshi Kings Topah, Leopoldo Spadea, Carlo Salati, Caterina Gagliano, Marco Zeppieri
Journal of Clinical Medicine. 2024; 13(4): 1047
[Pubmed]  [Google Scholar] [DOI]
2 Review of Retinal Imaging Modalities for Hydroxychloroquine Retinopathy
Kai Xiong Cheong, Charles Jit Teng Ong, Priya R Chandrasekaran, Jinzhi Zhao, Kelvin Yi Chong Teo, Ranjana Mathur
Diagnostics. 2023; 13(10): 1752
[Pubmed]  [Google Scholar] [DOI]
3 Retinal microvascular density analysis in patients with rheumatoid arthritis treated with hydroxychloroquine
Eliane Luisa Esser, Julian Alexander Zimmermann, Jens Julian Storp, Nicole Eter, Nataša Mihailovic
Graefe's Archive for Clinical and Experimental Ophthalmology. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 Hydroxychloroquine Causes Early Inner Retinal Toxicity and Affects Autophagosome–Lysosomal Pathway and Sphingolipid Metabolism in the Retina
Koushik Mondal, Hunter Porter, Jerome Cole, Hemang K. Pandya, Sandip K. Basu, Sufiya Khanam, Chi-Yang Chiu, Vinay Shah, Daniel J. Stephenson, Charles E. Chalfant, Nawajes Mandal
Molecular Neurobiology. 2022;
[Pubmed]  [Google Scholar] [DOI]
5 Evaluation of The Role of Spectral-Domain Optical Coherence Tomography in The Early Detection of Macular and Ganglion Cell Complex Thickness Changes in Patients with Rheumatologic Diseases Taking Hydroxychloroquine
Sevda Aydin Kurna, Hatice Selen Kanar, Murat Garli, Necati Çakir
Photodiagnosis and Photodynamic Therapy. 2022; : 102741
[Pubmed]  [Google Scholar] [DOI]
6 Longitudinal Retinal Changes Induced by Hydroxychloroquine in Eyes without Retinal Toxicity
Gonçalo Godinho, Carolina Madeira, Manuel Falcão, Susana Penas, Teresa Dinah-Bragança, Elisete Brandão, Ângela Carneiro, Renato Santos-Silva, Fernando Falcão-Reis, João Beato
Ophthalmic Research. 2021; 64(2): 290
[Pubmed]  [Google Scholar] [DOI]
7 Visual Impact of Early Hydroxychloroquine-Related Retinal Structural Changes in Patients with Systemic Lupus Erythematosus
Moataz A. Sallam, Arwa S. Beltagi, Mai A. Abdellatif, Magdy A. Awadalla
Ophthalmologica. 2021; 244(4): 301
[Pubmed]  [Google Scholar] [DOI]
8 Review of a controversial treatment method in the fight against COVID-19 with the example of Algeria
Hani Amir Aouissi, Mostefa Ababsa, Aissam Gaagai
Bulletin of the National Research Centre. 2021; 45(1)
[Pubmed]  [Google Scholar] [DOI]
9 Is optical coherence tomography angiography a useful tool in the screening of hydroxychloroquine retinopathy?
Hatice Nur Tarakcioglu, Abdullah Ozkaya, Ulviye Yigit
International Ophthalmology. 2021; 41(1): 27
[Pubmed]  [Google Scholar] [DOI]
10 Evaluating the Use of Hydroxychloroquine in Treating Patients With Rheumatoid Arthritis
Armaan M Nazir, Bhavya Koganti, Kunal Gupta, Marrium S Memon, Muhammad Bin Aslam Zahid, Vignarth Shantha Kumar, Mamatha Tappiti, Jihan A Mostafa
Cureus. 2021;
[Pubmed]  [Google Scholar] [DOI]
11 Spectral-Domain Optical Coherence Tomography in Hydroxychloroquine Retinopathy
Janine L. Johnston,Patty Darvill,Glen T.D. Thomson
Ophthalmology. 2014;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article